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SUMMARY
An outbreak of haemolytic uraemic syndrome (HUS) among children caused by infection with
sorbitol-fermenting enterohaemorrhagic Escherichia coli O157:Hx (SF EHEC O157:Hx)
occurred in Germany in 2002. This pathogen has caused several outbreaks so far, yet its reservoir
and routes of transmission remain unknown. SF EHEC O157:Hx is easily missed as most
laboratory protocols target the more common sorbitol non-fermenting strains. We performed
active case-finding, extensive exploratory interviews and a case-control study. Clinical and
environmental samples were screened for SF EHEC O157:Hx and the isolates were subtyped by
pulsed-field gel electrophoresis. We identified 38 case-patients in 11 federal states. Four
case-patients died during the acute phase (case-fatality ratio 11%). The case-control study could
not identify a single vehicle or source. Further studies are necessary to identify the pathogen’s
reservoir(s). Stool samples of patients with HUS should be tested with an adequate
microbiological set-up to quickly identify SF EHEC O157:Hx.
Key words : EHEC, foodborne infections, haemolytic uraemic syndrome, outbreak,
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INTRODUCTION
Haemolytic uraemic syndrome (HUS) is defined as
renal failure, thrombocytopenia and haemolytic ana-
emia and is the major cause of acute renal failure in
childhood. Its primary cause is infection with entero-
haemorrhagic Escherichia coli (EHEC), predomi-
nantly of serogroup O157 [1]. The inability to rapidly
ferment sorbitol is a widely used screening criterion to
differentiate this serogroup bacteriologically from
other E. coli. However, a sorbitol-fermenting (SF),
non-motile (Hx) EHEC O157 strain was first ident-
ified and characterized during an outbreak of HUS
in Bavaria in 1988 [2]. Before autumn 2002, three
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outbreaks associated with SF EHEC O157:Hx had
been identified in Germany, all of which were initially
recognized by an increase in the number of paediatric
patients with HUS which was not paralleled by an
increase of patients who experienced diarrhoea only
(‘HUS outbreak’) [2–4]. Moreover, all three out-
breaks occurred in colder months of the year, whereas
most EHEC outbreaks occur during summer and au-
tumn [5]. In only one of the outbreaks could a possible
source of infection be identified [3]. A case-control
study showed an association between illness and
consumption of a raw spreadable sausage containing
beef, but nomicrobiological confirmationwas possible
in the vehicle and trace-back to an animal reservoir
was impossible. Whereas cattle have been well estab-
lished as the major reservoir of EHEC O157:H7, to
our knowledge, so far no animal reservoir has yet
been identified for SF EHEC O157:Hx. Only rarely
could SF EHEC O157:Hx be isolated from animals :
twice from cattle [6, 7] and once from a pony [8].
During 1997–2000, SF EHEC O157:Hx were iso-
lated from 21/207 (10%) EHEC-associated HUS
patients during an active paediatric HUS surveillance
conducted in Germany and Austria [9]. SF EHEC
O157:Hx have also been sporadically identified in sev-
eral other European countries [7, 10–12], in Australia
[13] and Asia [14], and recently caused simultaneous
outbreaks in Scotland and northern England [15].
Several phenotypical and genetic features can be
used to differentiate between SF and non-sorbitol-
fermenting (NSF) EHEC O157, e.g. the lack of
tellurite resistance and urease genes [16, 17] and the
presence of the pilin subunit gene sfpA [18] in SF
EHEC O157.
In Germany, both the clinical diagnosis of HUS for
which an infectious aetiology cannot be ruled out
and laboratory diagnosis of human EHEC infection
have been notifiable diseases since 1998. Laboratory
criteria for notification of EHEC infection are detec-
tion of Shiga toxin production in an E. coli isolate or
amplification of Shiga toxin genes (stx1 or stx2) from
stool cultures [19]. In November 2002, six children
who had HUS with disease onset in October were re-
ported in Bavaria (compared with 10 HUS patients
reported in Bavaria during the whole of 2001). Con-
comitantly, the National Consulting Laboratory on
HUS (NCL-HUS) identified SF EHEC O157:Hx in
stools of 10 HUS patients in the course of 1 month.
An investigation was initiated in collaboration with
state and local health authorities to identify the out-
break’s source, and risk factors for transmission.
METHODS
Case ascertainment and epidemiological investigations
To identify and investigate patients as quickly as
possible, active case-finding was performed by con-
tacting all paediatric nephrology units and reference
laboratories in Germany. HUS was diagnosed clini-
cally by paediatric nephrologists. We defined case-
patients as children with onset of HUS between 1
October and 31 December 2002 (outbreak period) for
whom infection with SF EHEC O157:Hx could not
be ruled out. Among them, confirmed cases were
patients with culture-confirmed SF EHEC O157:Hx
infection, excluding HUS patients whose SF EHEC
O157:Hx isolates differed from the outbreak pattern
in pulsed-field gel electrophoresis (PFGE) by two or
more bands. Probable cases had only serological evi-
dence of a recent E. coli O157 infection based on the
detection of IgM antibodies against O157 lipopoly-
saccharide (LPS). Possible cases had no laboratory
tests or results that did not definitely exclude an SF
EHEC O157:Hx infection.
After obtaining informed consent, the parents/
guardians of case-patients were questioned through
telephone interviews utilizing a 28-page specifically
designed questionnaire concerning symptoms, food
consumption, contact persons, travel history and con-
tact with animals. In addition, a record of the daily
activities and routines in the 4 days prior to symptom
onset was obtained. As children with a migration
background (i.e. cases or parents born outside
Germany) appeared to be overrepresented among
cases, households of four case-patients with a mi-
gration background from the state of Baden-Wuert-
temberg were inspected regarding their living
environment and a prevalence survey of food items
present in the households was conducted. In early
exploratory interviews, the consumption of apples
picked up from the ground by individuals and of
apple juice made from these apples was frequently
reported. The juice was locally produced on a small
scale and often unpasteurized. To test the hypothesis
that disease was associated with consumption of this
type of apple juice, we conducted a case-control study
including case-patients with disease onset between
1 October and 10 December. Due to the limited
number of cases, we included case-patients whose in-
formation originally had given rise to the hypothesis.
Control individuals were randomly selected from no-
tifications of infections with Campylobacter spp. and
frequency-matched by federal state and age group.
390 K. Alpers and others
The questionnaire asked about household size and dis-
tance to the next farm, travel, contact with animals,
and about food consumed by the child and the child’s
household members. Particular emphasis was placed
on consumption of home-made or locally produced
apple juice, and consumption or collection of apples.
Information was collected on several exposure peri-
ods including the week prior to disease onset (for case-
patients) or interview (for controls) as well as the time
since October 2002 and during the entire calendar
year. Additionally, we asked about the frequency of
consumption of these foodstuffs in the household.
Data entry was performed with Epi Info version 6
(Epi InfoTM, CDC, Atlanta, GA, USA), bivariate
analysis was performed using Epi Info software ver-
sion 6 and version 2000. Exact confidence intervals
(CI) were determined using Statcalc. Exact logistical
regression was performed including possible risk-
factors found in bivariate analysis to account for
possible interaction, using Stata version 10 (command
EXLOGISTIC ; StataCorp, College Station, TX, USA)
with federal state and age group as strata variables.
Microbiological and molecular investigations
Stool samples from HUS patients and their contacts
were analysed at the NCL-HUS and the National
Reference Centre for Salmonella and other enteric
pathogens (NRC-Sal) for the presence of SF EHEC
O157:Hx using immunomagnetic separation, culture
on sorbitol MacConkey agar (SMAC) and entero-
haemolysin agar and polymerase chain reaction
(PCR) screening of the primary stool cultures for stx,
eae, rfbO157, and sfpA as described previously [18].
Isolates were subtyped by PFGE following the
PulseNet protocol of CDC, Atlanta [20] and the
PFGE patterns were analysed with BioNumerics,
version 4.5 (Applied Maths BVBA, Belgium) at the
NRC-Sal. If available, the sera of HUS patients were
screened for IgM and IgG antibodies to O157 LPS
[21, 22].
Environmental and contact investigations
Samples obtained from the environment and contacts
of the patients were analysed by PCR for the presence
of rfbO157 and stx genes [18], and for the production
of Shiga toxin (Stx) by an in-house Gb3-receptor
enzyme immunoassay in the Veterinary National
Reference laboratory for E. coli in Dessau, Germany.
RESULTS
Case ascertainment and epidemiological investigations
We identified 48 paediatric HUS patients during the
outbreak period. Of these, 38 children met the defi-
nition for cases related to this outbreak (Fig. 1) : we
classified 22 as confirmed cases, 13 as probable and
three as possible cases. Ten HUS patients were con-
sidered unrelated to this outbreak. In stool samples of
five of these patients, SF EHEC O157:Hx were iso-
lated which differed in the PFGE pattern by two or
more bands from the outbreak strain; of these, two
SF EHEC O157:Hx strains were stx-negative. From
five other HUS patients, a non-O157 EHEC was iso-
lated. A total of four (two confirmed, two probable)
case-patients died during the acute phase of the dis-
ease, resulting in a case-fatality ratio of 11% (95% CI
4–26) for confirmed and probable cases combined.
The median age of the 22 confirmed case-patients
was 2.7 years (range 1–9 years) ; 11 were males.
Nineteen (86%) lived in the two southern German
states of Bavaria and Baden-Wuerttemberg (Fig. 2).
Seven (32%) of the confirmed case-patients had a
migrant background [the cases themselves or their
parents originated from countries of the former Soviet
Union (3x), Turkey (2x), and Kosovo (1x) ; one de-
clined to specify]. Case-patients without a migrant
background were more likely to live in rural areas.
None of the case-patients lived in a town with more
than 50000 inhabitants, compared to 22% of families
with children aged <15 years in the general popu-
lation according to 2001 microcensus data of the
German Federal Statistical Office (P=0.02). Inspec-
tion of the living environment of four households


















Fig. 1. Possible (%), probable ( ) and confirmed ( ) case-
patients in an outbreak of haemolytic uraemic syndrome
due to sorbitol-fermenting EHEC O157:Hx in Germany by
week of onset, October–December 2002 (n=38). +, Fatal
case.
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identify a commonality. In the food prevalence sur-
vey, food items of the same brand were never found in
more than two households.
In the case-control study, data from 16 case-
patients (11 confirmed, 5 possible) and 67 controlswere
analysed. Self-reporting of the case-patients revealed
that 11 (67%) had vomited, and 12 (75%) had had
diarrhoea (among them seven with bloody diarrhoea).
All children were admitted to hospital with a median
duration of 34 days of hospitalization (range 7–42,
number of days missing for one child, four children
were still in the hospital at the time of the interview).
Case-patients and controls lived predominantly in
rural areas of Germany. Moreover, 8/11 (72%) case-
patients and 42/61 (69%) controls for whom we could
obtain the information lived within 1 km of a farm;
five controls (7.5%) and no case-patient lived on a
farm.
In bivariate analysis, the occurrence of HUS was
associated with the consumption of apple juice [odds
ratio (OR) 6.6, 95% exact CI 1.5–27.45] (one control
excluded due to a ‘don’t know’ answer). However, the
information available indicated that the apples used
in preparing the apple juice were obtained from vari-
ous orchards and the juice was produced by different
manufacturers. HUS was also significantly associated
with a type of fruit-laced and sweetened ‘quark’
product popular with children in Germany (OR 4.8,
95% exact CI 1.3–19.6). Quark is a fresh curdled
cheese akin to farmer’s cheese produced from pas-
teurized milk by fermentation with lactobacilli and/or
renin. After fermentation the whey is removed and
cream, sugar and fruit are added. A variety of differ-
ent brands were mentioned for this type of quark
preparation, which is packaged like small servings of
yoghurt. Five cases (31%) vs. four controls (6%) had
consumed apple juice as well as quark. The results of
exact conditional logistic regression suggest that both
risk factors are not independently associated with in-
fection (Table 1).
None of the cases had consumed raw milk vs. 12
controls (18%) who had. Consumption of sausages,
minced meat or salad was not found to be associated
with infection.
Environmental and contact investigations
EHEC was not isolated from apples from case-
patients’ households, apple juice and environmental
samples (soil, leaves, sand and dog faeces) ; all also
tested negative for EHEC in the enzyme immuno-
assay and PCR tests.
In only three of the infected patients (19%), did
the parent/guardian mention having had diarrhoea
in the week preceding the onset of symptoms in the
child. Contact investigations were incomplete, but
in Bavaria only three EHEC-positive stools were
found in contacts to four confirmed cases-patients
(total number tested not known). During the out-
break period, there was no corresponding increase in
notifiable EHEC infections: between October and
December 2002, 340 EHEC infections were notified in
Germany compared to 305 between October and
December 2002 (http://www3.rki.de/SurvStat/).
DISCUSSION
We report the largest known outbreak of paediatric
HUS due to SF EHEC O157:Hx thus far. It was
characterized by a high case-fatality ratio and the
absence of a recognized increase of EHEC-associated
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Fig. 2. Possible, probable and confirmed case-patients in an
outbreak of haemolytic uraemic syndrome due to sorbitol-
fermenting EHEC O157:Hx in Germany by place of resi-
dence, October–December 2002 (n=38).
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appeared to be geographically dispersed and protrac-
ted. Case-patients lived predominantly in rural areas.
Despite intense efforts, which included exhaustive
questioning of members of case-patients’ families and
a food prevalence survey in selected households, we
were unable to identify a common source for this
outbreak. The case-control study suggested a statisti-
cal association of illness with having consumed locally
produced apple juice and a quark product. The stat-
istical analysis could not resolve which of the two may
have been the vehicle of infection. Unpasteurized
apple juice has been implicated in several outbreaks
caused by EHEC O157:H7 to the acid tolerance of
these organisms [23]. Thus, apple juice would have
been a plausible vehicle. However, the consumption
of apple juice was reported by only 44% of the cases
and apples consumed by the patients were not ob-
tained from a common collection or production site.
Furthermore, cases continued to occur after com-
pletion of the case-control study, and most of these
later case-patients denied having consumed locally
produced apple juice. Moreover, only one of the case-
patients with a migrant background reported con-
sumption of apple juice. Consumption of locally
produced apple juice may have been a surrogate fac-
tor for a rural exposure or season of the year, because
apple picking and delivery to local manufacturers are
autumn activities and apples are typically harvested
in rural areas. However, controls, randomly selected
among children with notified Campylobacter spp. in-
fection, were similar to the case-patients in the sense
that they were also predominantly rural. Thus, they
should have had similar opportunities to consume
locally produced apple juice. Regarding the associ-
ation of the quark product and disease, a causal role is
rendered unlikely by the broad variety of brands in-
volved. However, it was not possible to trace back all
ingredients to their origins. Hence, we cannot exclude
that one of the components of the quark stemmed
from the same production source and may have had
some causal relation with the infection or was associ-
ated with the true risk factor.
The case occurrence in this and also in previous
German SF EHEC O157:Hx outbreaks seems to
point to a distinct epidemiology of human infection
associated with these strains that differs from those
caused by NSF EHEC O157. The protracted and
widespread distribution of cases is compatible with a
widely distributed food vehicle with a long shelf-life
or that had been repeatedly contaminated. Reasons
for our inability to identify a common vehicle may lie
in incomplete recording of case-patients’ food history,
incomplete recall of parents/guardians (e.g. ubiqui-
tous vehicles such as some spices), existence of more
than one contaminated vehicle or transmission route,
or a combination of these factors. Alternatively, the
repeated failure to identify a common food vehicle,
despite extensive evaluation of food history, may in-
dicate an unrecognized environmental risk rather
than a foodborne risk.
The scattered distribution and the absence of a
corresponding increase in non-HUS SF EHEC
O157:Hx infections raises the question of whether
there might be a genetic or other predisposing factor
for HUS once infected with this specific strain. An
association between blood group and HUS has
already been suggested [24]. The role of a genetic
factor would also fit the observation of a higher than
representative proportion of case-patients with a
migrant background, as the genetic pool of migrant
populations may be different from the majority
population. In the states of former West Germany,
21% of the 2005 population had a migrant back-
ground, compared to 32% of the confirmed cases
(P=0.3). Region-specific information for the state or
area where the outbreak took place is not available.
Table 1. Risk factors for HUS in an outbreak of HUS due to





(n=67) aOR 95% CI
Consumption of locally
produced apple juice
7 (44%) 7 (11%) 8.8 0.6–116.4
Consumption of ‘quark’ 11 (69%) 21 (31%) 4.7 0.8–35.3
Interaction
5 (31%) 4 (6%) 0.4 0.0–11.0Apple juice * quark
HUS, Haemolytic uraemic syndrome; aOR, adjusted odds ratio ; CI, confidence
interval.
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As the outbreak affected mainly rural areas, the pro-
portion of inhabitants with a migrant background can
be assumed to be lower than the West German aver-
age because urban areas tend to have higher propor-
tions of migrant population. Alternatively, SF EHEC
O157:Hx could possess virulence determinants not
present in NSF EHEC O157 in addition to stx2 and
eae, which are considered the major virulence factors
of EHEC [25–27]. In an outbreak of SF EHEC
O157:Hx infection in Scotland, 17 cases with diar-
rhoea were identified and of these, eight (47%) pro-
gressed to HUS [28]. During a 10-year period, we
followed 18 sporadic patients with diarrhoea caused
by SF EHEC O157:Hx and of these 12 (66.6%) de-
veloped HUS (H. Karch, personal communication).
These independent findings may indicate an even
higher virulence of SF EHEC O157:Hx than that of
NSF EHEC O157.
This outbreak could only be detected because
the stool samples were cultured on tellurite-free
media, which allow growth of tellurite-sensitive SF
EHEC O157 [17]. By using cefixime-tellurite sorbitol
MacConkey agar, which is a common selective
medium for the isolation of tellurite-resistant NSF
EHEC O157:H7 this outbreak would have been mis-
sed. By applying conventional criteria to interpret
PFGE patterns with regard to outbreak relatedness,
we excluded almost as many HUS patients with SF
EHEC O157:Hx as are usually identified during a
whole year. However, subsequently to the investi-
gation of this outbreak, we have recently shown that
PFGE patterns of SF EHEC O157:Hx can change
during the course of an outbreak [29] and that strains
can loose their stx genes [22, 29]. Therefore, it is
possible that some of the excluded patients were mis-
classified and were actually part of the outbreak.
We conclude that SF EHEC O157:Hx probably
have a higher virulence than NSF EHEC O157 and
have the potential to cause large HUS outbreaks. The
apparently high virulence of SF EHEC O157:Hx ne-
cessitates the need to urgently identify the pathogen’s
reservoir(s) and vehicles of infection, and to deter-
mine whether there are genetic or other predisposing
factors for infection with this strain. For a more ac-
curate exposure assessment of SF EHEC O157:Hx
infected patients, rapid identification of these patients
is crucial. Therefore, continued enhanced surveillance
of HUS is needed in combination with an adequate
microbiological set-up to quickly recognize SF
EHEC O157:Hx. This pathogen is easily missed as
most laboratory protocols target the more common
sorbitol non-fermenting strains. Stool samples of
HUS patients should be tested by culture on tellurite-
free media, immunomagnetic separation or nucleid
acid-based methods. Future outbreaks as well as
sporadic patients with an infection with this pathogen
should be expediently investigated, including a more
thorough exploration of possible environmental
transmission routes.
Considering the findings of this outbreak, in keep-
ing with the results of a case-control study of risk
factors for sporadic EHEC-associated illness in
Germany [30], future outbreak investigations should
place emphasis on extensive recording of outdoor ac-
tivities, and outbreak investigations should also in-
clude screening of household contacts for possible SF
EHEC O157:Hx carriage.
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